On April 23, 2025, Rafael Holdings, Inc. announced that William Conkling resigned as CEO, effective May 31, 2025, and Howard Jonas will take over as CEO starting June 1, 2025. The company also revealed various financial transactions with Cornerstone Pharmaceuticals, showing a significant ownership stake of 67%.